atropine has been researched along with Glucose Intolerance in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunai, J; Kilpatrick, CR; Oestricker, LZ; Patterson, BW; Reeds, DN; Sterl, K; Wallendorf, MJ; Wang, S; Wice, BM | 1 |
| Fagerholm, V; Rahkonen, O; Savontaus, E; Scheinin, M | 1 |
2 other study(ies) available for atropine and Glucose Intolerance
| Article | Year |
|---|---|
Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance.
Topics: Adult; Atropine; Blood Glucose; Cross-Over Studies; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucose Intolerance; Heart Rate; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Neurotensin; Pancreatic Polypeptide; Receptors, Cholinergic; Signal Transduction | 2018 |
Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in alpha2A-adrenoceptor knockout mice.
Topics: Adrenergic beta-Antagonists; Animals; Atropine; Blood Glucose; Corticosterone; Fasting; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Insulin; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscarinic Antagonists; Propranolol; Receptors, Adrenergic, alpha-2; Time Factors | 2008 |